Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 2

Interventions

Adalimumab 10Etanercept 9Methotrexate 4Infliximab 3tofacitinib 2Rituximab 2Leflunomide 2Abatacept 2tocilizumab 1sarilumab 1golimumab 1entecavir 1Tumor Necrosis Factor Inhibitors 1Sulfasalazine 1Prednisone 1Licensure 1Hydroxychloroquine 1Glucocorticoids 1Folic Acid 1Chloroquine 1Certolizumab Pegol 1Azathioprine 1Antirheumatic Agents 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Arthritis, Rheumatoid × tofacitinib × Clear all
NCT03976245 2024-11-29

Advanced Therapeutics in Rheumatoid Arthritis (RA)

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 4 Recruiting
144 enrolled

Arthritis, Rheumatoid

NCT02092467 2021-08-17

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Pfizer

Phase 4 Completed
4,372 enrolled 22 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡